Researchers at Monash University have developed a copper-based drug that shows promise in restoring memory and clearing toxic proteins associated with Alzheimer's disease. The treatment targets amyloid-beta plaques and tau tangles, two key pathological features of the neurodegenerative condition. The breakthrough represents a significant advancement in the search for effective Alzheimer's therapies, though human trials are still needed.
Background
Alzheimer's disease is a progressive neurodegenerative disorder affecting millions worldwide, characterized by memory loss and cognitive decline. Current treatments only manage symptoms rather than addressing the underlying causes of the disease.
- Source
- Hacker News (RSS)
- Published
- Jun 15, 2026 at 10:48 PM
- Score
- 8.0 / 10